
NUVB
Nuvation Bio Inc. Class A
$4.69
-$0.03(-0.64%)
33
Overall
50
Value
27
Tech
23
Quality
Market Cap
$1.69B
Volume
2.72M
52W Range
$1.57 - $9.75
Target Price
$12.56
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | -- | -- | $7.9M | $62.9M | ||
| Total Revenue | -- | -- | -- | -- | $7.9M | $62.9M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | -- | -- | -- | -- | $7.1M | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | -- | -- | -- | $7.9M | $62.9M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $43.6M | $93.3M | $119.7M | $99.8M | $600.5M | $276.0M | ||
| Research & Development | $32.6M | $69.0M | $87.8M | $71.3M | $99.1M | $115.1M | ||
| Research Expense | $32.6M | $69.0M | $87.8M | $71.3M | $99.1M | $115.1M | ||
| Selling, General & Administrative | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | $154.6M | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | $2.4M | ||
| General & Administrative Expenses | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | $152.3M | ||
| Salaries & Wages | -- | -- | -- | $19.5M | -- | -- | ||
| Depreciation & Amortization | $100.0K | $200.0K | $200.0K | $200.0K | -- | -- | ||
| Depreciation & Amortization | $100.0K | $200.0K | $200.0K | $200.0K | -- | -- | ||
| Other Operating Expenses | -- | $-893.0K | $-2.5M | $-1.0M | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-43.6M | $-93.3M | $-119.7M | $-99.8M | $-592.6M | $-213.1M | ||
| EBITDA | $-43.4M | $-93.1M | $-119.5M | $-75.6M | $-567.5M | $-188.5M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $341.0K | $13.7M | ||
| Intinc | $1.9M | $3.0M | $7.4M | $24.6M | $27.1M | $21.4M | ||
| Net Non-Operating Interest Income/Expense | $1.9M | $3.0M | $7.4M | $24.6M | $26.7M | $7.7M | ||
| Gain on Sale of Securities | $218.0K | $-80.0K | $-1.2M | $-139.0K | $-12.0K | $5.0K | ||
| Other Income/Expense | $-218.0K | $-1.4M | $8.1M | $-6.1M | $1.2M | $-2.2M | ||
| Other Special Charges | -- | $4.2M | $10.2M | $497.0K | $-1.0M | $1.4M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | $7.4M | -- | -- | -- | ||
| Special Income Charges | -- | -- | $-7.4M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-43.6M | $-93.3M | $-119.7M | $-75.8M | $-568.1M | $-190.9M | ||
| Pre-Tax Income | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | $-204.6M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | -- | -- | -- | $-537.0K | -- | ||
| NET INCOME | ||||||||
| Net Income | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | $-204.6M | ||
| Net Income (Continuing Operations) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | $-204.6M | ||
| Net Income (Discontinued Operations) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | $-204.6M | ||
| Net Income (Common Stockholders) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | $-204.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-202.5M | ||
| TOTALS | ||||||||
| Total Expenses | $43.6M | $93.3M | $119.7M | $99.8M | $600.5M | $276.0M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $97.5M | $197.9M | $216.7K | $218.9K | $268.8K | $341.5K | ||
| Average Shares Outstanding (Diluted) | $97.5M | $197.9M | $216.7K | $218.9K | $268.8K | $341.5K | ||
| Shares Outstanding | $217.7M | $219.1M | $218.8M | $219.0M | $338.7M | $347.6M | ||
| Basic EPS | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | $-0.60 | ||
| Basic EPS (Continuing Operations) | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | $-0.60 | ||
| Diluted EPS | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | $-0.60 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-0.48 | $-0.35 | $-2.11 | $-0.60 | ||
| OTHER METRICS | ||||||||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | $-33.0K | ||
| Other Gand A | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | $152.3M | ||
| Selling Expense | -- | -- | -- | -- | -- | $2.4M | ||
| Restruct | -- | -- | $7.4M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NUVB | $4.69 | -0.6% | 2.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nuvation Bio Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW